16.01.2015 Views

Biosafety Guidelines For Research On Genetically Modified ...

Biosafety Guidelines For Research On Genetically Modified ...

Biosafety Guidelines For Research On Genetically Modified ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

6.5 SUPPLY OF GENETICALLY MANIPULATED MATERIAL TO OTHER<br />

RESEARCH WORKERS<br />

6.5.1 Investigators supplying people in Singapore with genetically manipulated<br />

material shall make sure that recipients who are unfamiliar with the genetic<br />

manipulation field are made aware of the existence of these guidelines and of<br />

the need to observe them.<br />

6.5.2 When genetically manipulated organisms are supplied to investigators<br />

overseas, the requirements of Article 19.4 of the Convention on Biological<br />

Diversity (http://www.biodiv.org/chm/conv/art.htm), must be met. Article 19.4<br />

stipulates that:<br />

Each Contracting Party shall, directly or by requiring any<br />

natural or legal person under its jurisdiction providing the<br />

organisms referred to in paragraph 3 above * , provide any<br />

available information about the use and safety regulations<br />

required by that Contracting Party in handling such<br />

organisms, as well as any available information on the<br />

potential adverse impact of the specific organisms concerned<br />

to the Contracting Party into which those organisms are to be<br />

introduced.<br />

To make sure that Singapore's responsibility as an exporter with respect to<br />

Article 19.4 is satisfied, individuals or organisations exporting genetically<br />

manipulated organisms must provide the following information to authorities in<br />

the recipient country.<br />

• details of the risk assessments that have been carried out in Singapore, and<br />

the conditions under which the organism has been approved for use in<br />

Singapore (e.g. contained use in a BSL2 laboratory, or small scale field trial<br />

under specified conditions);<br />

• any information known to the sender about possible adverse effects of the<br />

organism in the recipient country. (In many cases, a disclaimer that no<br />

assessment has been made of potential effects in the recipient country may<br />

be suitable.)<br />

* ‘Any living modified organism resulting from biotechnology that may have adverse effect on the conservation and<br />

sustainable use of biological diversity.’<br />

Page 22

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!